127 related articles for article (PubMed ID: 38477524)
1. [Cost-effectiveness analysis of a vaccine for Helicobacter pylori in southern Europe].
Arcos-Machancoses JV; Romero Prada M; Crehuá Gaudiza E; Martínez Costa C
Rev Esp Salud Publica; 2024 Mar; 98():. PubMed ID: 38477524
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of a potential prophylactic Helicobacter pylori vaccine in the United States.
Rupnow MF; Chang AH; Shachter RD; Owens DK; Parsonnet J
J Infect Dis; 2009 Oct; 200(8):1311-7. PubMed ID: 19751153
[TBL] [Abstract][Full Text] [Related]
3. Prophylaxis of cervical cancer and related cervical disease: a review of the cost-effectiveness of vaccination against oncogenic HPV types.
Armstrong EP
J Manag Care Pharm; 2010 Apr; 16(3):217-30. PubMed ID: 20331326
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness analysis of different screening strategies for helicobacter pylori infection in Iran: A model-based evaluation.
Yousefi M; Rezaei S; Khoshbaten M; Sarmasti M
Helicobacter; 2023 Dec; 28(6):e13027. PubMed ID: 37839058
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of
Kowada A
Scand J Gastroenterol; 2019 Jun; 54(6):685-689. PubMed ID: 31190581
[No Abstract] [Full Text] [Related]
6. Endoscopy Is Cost-Effective for Gastric Cancer Screening After Successful Helicobacter pylori Eradication.
Kowada A
Dig Dis Sci; 2021 Dec; 66(12):4220-4226. PubMed ID: 33417196
[TBL] [Abstract][Full Text] [Related]
7. Helicobacter pylori vaccine development and use: a cost-effectiveness analysis using the Institute of Medicine Methodology.
Rupnow MF; Owens DK; Shachter R; Parsonnet J
Helicobacter; 1999 Dec; 4(4):272-80. PubMed ID: 10597398
[TBL] [Abstract][Full Text] [Related]
8. Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding.
Leontiadis GI; Sreedharan A; Dorward S; Barton P; Delaney B; Howden CW; Orhewere M; Gisbert J; Sharma VK; Rostom A; Moayyedi P; Forman D
Health Technol Assess; 2007 Dec; 11(51):iii-iv, 1-164. PubMed ID: 18021578
[TBL] [Abstract][Full Text] [Related]
9. The cost effectiveness of Helicobacter pylori population screening-economic evaluation alongside a randomised controlled trial with 13-year follow-up.
Høgh MB; Kronborg C; Hansen JM; Schaffalitzky de Muckadell OB
Aliment Pharmacol Ther; 2019 Apr; 49(8):1013-1025. PubMed ID: 30854700
[TBL] [Abstract][Full Text] [Related]
10. Cost-Effectiveness Analysis of the Helicobacter Pylori Screening Programme in an Asymptomatic Population in China.
Feng T; Zheng Z; Xu J; Cao P; Gao S; Yu X
Int J Environ Res Public Health; 2022 Aug; 19(16):. PubMed ID: 36011621
[TBL] [Abstract][Full Text] [Related]
11. Quality of life measurement clarifies the cost-effectiveness of Helicobacter pylori eradication in peptic ulcer disease and uninvestigated dyspepsia.
Groeneveld PW; Lieu TA; Fendrick AM; Hurley LB; Ackerson LM; Levin TR; Allison JE
Am J Gastroenterol; 2001 Feb; 96(2):338-47. PubMed ID: 11232673
[TBL] [Abstract][Full Text] [Related]
12. Both family-based Helicobacter pylori infection control and management strategy and screen-and-treat strategy are cost-effective for gastric cancer prevention.
Ma J; Yu M; Shao QQ; Yu XC; Zhang C; Zhao JB; Yuan L; Qi YB; Hu RB; Wei PR; Xiao W; Chen Q; Jia BL; Chen CL; Lu H; Ding SZ
Helicobacter; 2022 Aug; 27(4):e12911. PubMed ID: 35706404
[TBL] [Abstract][Full Text] [Related]
13. Economic and health impacts of introducing Helicobacter pylori eradication strategy into national gastric cancer policy in Japan: A cost-effectiveness analysis.
Kowada A; Asaka M
Helicobacter; 2021 Oct; 26(5):e12837. PubMed ID: 34278663
[TBL] [Abstract][Full Text] [Related]
14. The health economics of Helicobacter pylori infection.
Moayyedi P
Best Pract Res Clin Gastroenterol; 2007; 21(2):347-61. PubMed ID: 17382282
[TBL] [Abstract][Full Text] [Related]
15. Economic and health impacts of Helicobacter pylori eradication strategy for the treatment of peptic ulcer disease: A cost-effectiveness analysis.
Kowada A; Asaka M
Helicobacter; 2022 Jun; 27(3):e12886. PubMed ID: 35343031
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of hepatitis A vaccination in Indonesia.
Suwantika AA; Beutels P; Postma MJ
Hum Vaccin Immunother; 2014; 10(8):2342-9. PubMed ID: 25424941
[TBL] [Abstract][Full Text] [Related]
17. Cost-Effectiveness of Screening Helicobacter pylori for Gastric Cancer Prevention: a Systematic Review.
Sarmasti M; Khoshbaten M; Khalili F; Yousefi M
J Gastrointest Cancer; 2022 Dec; 53(4):1093-1103. PubMed ID: 34694594
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of a potential future Helicobacter pylori vaccine in the Netherlands: the impact of varying the discount rate for health.
de Vries R; Klok RM; Brouwers JR; Postma MJ
Vaccine; 2009 Feb; 27(6):846-52. PubMed ID: 19084566
[TBL] [Abstract][Full Text] [Related]
19. Quantifying the population impact of a prophylactic Helicobacter pylori vaccine.
Rupnow MF; Shachter RD; Owens DK; Parsonnet J
Vaccine; 2001 Dec; 20(5-6):879-85. PubMed ID: 11738753
[TBL] [Abstract][Full Text] [Related]
20. Re-evaluating cost effectiveness of universal meningitis vaccination (Bexsero) in England: modelling study.
Christensen H; Trotter CL; Hickman M; Edmunds WJ
BMJ; 2014 Oct; 349():g5725. PubMed ID: 25301037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
